Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06095297 · ClinicalTrials.gov registry record · NA

Long COVID Brain Fog: Cognitive Rehabilitation Trial

A NA study of Cognitive Impairment and Long COVID, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06095297 is a NA study of Cognitive Impairment and Long COVID that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06095297, a NA study of Cognitive Impairment and Long COVID, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will compare two approaches to cognitive rehabilitation in adults with long COVID with persistent, mild to moderate, cognitive impairment. One approach will feature (A) web-based computer "games" that trains how quickly individuals process information that they receive through their senses; (B) in-lab training on everyday activities with important cognitive components, (C) procedures designed to transfer improvements in cognition from the treatment setting to everyday life, and (D) a non-invasive form of vagus nerve stimulation (VNS), i.e., trans-auricular VNS (taVNS). Component B will include work-related tasks. This approach is termed Constraint-Induced Cognitive Therapy (CICT). The other approach will feature (A) web-based computer "games" that train reaction time and eye-hand coordination; (B) in-lab training on relaxation, healthy nutrition, and healthy sleep, (C) procedures designed to promote integration of these lifestyle changes into everyday life, and (D) taVNS. This approach is termed Brain Fitness Training (BFT). A subset of participants, who qualify for and and desire vocational rehabilitation (VR), will receive VR from the Alabama Department of Rehabilitation Services (ADRS) in addition to CICT or BFT. ADRS VR will include career counseling, prescription of on-the-job accommodations, and guidance on return-to-work. Those in the CICT + VR group will also receive on-the-job coaching from a peer mentor for a month after completing training. CICT, with or without VR, will involve 30 hours of training. Ten 3-hour in-lab, face-to-face, therapist-directed sessions will be scheduled. These sessions will feature one hour of gaming; the remainder will be committed to in-lab training on the target behaviors and the procedures designed to promote transfer of therapeutic gains to daily life and improving skills essential to work; the set of the latter procedures is termed the Transfer Package. ta-VNS will administered for 10 minutes before gaming and i

Interventions

  • BEHAVIORAL Processing Speed Training
  • BEHAVIORAL In-lab Instrumental Activities of Daily Living Training
  • BEHAVIORAL In-lab Brain Health Training
  • BEHAVIORAL Transfer Package
  • BEHAVIORAL Follow Up Phone Calls

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-04-25
Est. Completion 2027-04
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06095297

The ClinicalTrials.gov registry entry for NCT06095297 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (95% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 5 interventions - of which Processing Speed Training is the first listed.

NCT06095297 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06095297 about?

NCT06095297 is a clinical study titled "Long COVID Brain Fog: Cognitive Rehabilitation Trial". This study will compare two approaches to cognitive rehabilitation in adults with long COVID with persistent, mild to moderate, cognitive impairment. One approach will feature (A) web-based computer "games" that trains how quickly individuals process information that they receive through their sense...

What is the current status of trial NCT06095297?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-04-25. Estimated completion is 2027-04.

What conditions does trial NCT06095297 study?

This clinical trial studies the following conditions: Cognitive Impairment, Long COVID, Cognitive Dysfunction, Post-Acute COVID-19 Syndrome, Brain Fog.

What interventions are being tested in trial NCT06095297?

The interventions under investigation include: Processing Speed Training (BEHAVIORAL), In-lab Instrumental Activities of Daily Living Training (BEHAVIORAL), In-lab Brain Health Training (BEHAVIORAL), Transfer Package (BEHAVIORAL), Follow Up Phone Calls (BEHAVIORAL).

Who is sponsoring clinical trial NCT06095297?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06095297 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.